相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiotoxicity of cyclophosphamide's metabolites: an in vitro metabolomics approach in AC16 human cardiomyocytes
Flavio Dionisio et al.
ARCHIVES OF TOXICOLOGY (2022)
Trends in heart disease mortality among breast cancer survivors in the US, 1975-2017
Jacqueline B. Vo et al.
BREAST CANCER RESEARCH AND TREATMENT (2022)
Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death
Chun-Yan Kong et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
The effects of doxorubicin on cardiac calcium homeostasis and contractile function
Krekwit Shinlapawittayatorn et al.
Journal of Cardiology (2022)
Saikosaponin D Alleviates DOX-induced Cardiac Injury In Vivo and In Vitro
Yan-Jing Zhang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2022)
Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy
Kalyan R. Chitturi et al.
CURRENT ONCOLOGY REPORTS (2022)
Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents
Run Yang et al.
INFLAMMOPHARMACOLOGY (2022)
Cardiac Dysfunction Promotes Cancer Progression via Multiple Secreted Factors
Lama Awwad et al.
CANCER RESEARCH (2022)
Cardiac Remodeling in the Absence of Cardiac Contractile Dysfunction Is Sufficient to Promote Cancer Progression
Lama Awwad et al.
CELLS (2022)
Cardiotoxicity evaluation and comparison of diterpene alkaloids on zebrafish
Qiang Ye et al.
DRUG AND CHEMICAL TOXICOLOGY (2021)
Investigation of the Antihypertrophic and Antifibrotic Effects of Losartan in a Rat Model of Radiation-Induced Heart Disease
Monika Gabriella Kovacs et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes
A. D. Podgurskaya et al.
SCIENTIFIC REPORTS (2021)
Emerging roles of microRNA-208a in cardiology and reverse cardio-oncology
Xiang Wang et al.
MEDICINAL RESEARCH REVIEWS (2021)
The positive role of traditional Chinese medicine as an adjunctive therapy for cancer
Xiaoyi Zhang et al.
BIOSCIENCE TRENDS (2021)
Dynamic observation of 5-fluorouracil-induced myocardial injury and mitochondrial autophagy in aging rats
Yuanyang Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Cardiotoxicities of novel cancer immunotherapies
Ashley F. Stein-Merlob et al.
HEART (2021)
Bevacizumab-Induced Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and ERK Inactivation Contribute to Cardiotoxicity
Yue Li et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Regulated cell death pathways in doxorubicin-induced cardiotoxicity
Effimia Christidi et al.
CELL DEATH & DISEASE (2021)
Cardiovascular Toxicities of CAR T-cell Therapy
Nikita P. Patel et al.
CURRENT ONCOLOGY REPORTS (2021)
Efficacy of Alkaloids in Alleviating Myocardial Ischemia-Reperfusion Injury in Rats: A Meta-Analysis of Animal Studies
Shuai Wang et al.
BIOMED RESEARCH INTERNATIONAL (2021)
A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
Yun Cai et al.
FRONTIERS IN PHARMACOLOGY (2021)
Cardiotoxicity in cancer immune-checkpoint therapy: Mechanisms, clinical evidence, and management strategies
Jin-Yu Sun et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer
Eiko Hayase et al.
GENOME MEDICINE (2021)
Evaluation of renal cancer progression in a mouse model of heart failure
Canxia Shi et al.
CANCER COMMUNICATIONS (2021)
Effect of spironolactone use in pulmonary arterial hypertension - analysis from pivotal trial databases
Zeenat Safdar et al.
PULMONARY CIRCULATION (2021)
Saponins in Cancer Treatment: Current Progress and Future Prospects
Olusola Olalekan Elekofehinti et al.
PATHOPHYSIOLOGY (2021)
Structural Transcatheter Cardiac Interventions in the Cardio-Oncology Population
Daniel J. Jimenez et al.
CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE (2021)
Structural Transcatheter Cardiac Interventions in the Cardio-Oncology Population
Daniel J. Jimenez et al.
CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE (2021)
Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B
Wencong Tian et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2020)
Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities
Mingchuan Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Coenzyme Q10 Cardioprotective Effects Against Doxorubicin-Induced Cardiotoxicity in Wistar Rat
Ana Flavia M. Botelho et al.
CARDIOVASCULAR TOXICOLOGY (2020)
Cardiotoxicity of sorafenib is mediated through elevation of ROS level and CaMKII activity and dysregulation of calcium homoeostasis
Wenzhuo Ma et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2020)
Flavonoids as anticancer therapies: A systematic review of clinical trials
Angela Bisol et al.
PHYTOTHERAPY RESEARCH (2020)
Signaling Pathways Underlying Anthracycline Cardiotoxicity
Valentina Sala et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes
Xiaoxue Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling
Wang Qi et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
A review of cancer immunotherapy toxicity
Lucy Boyce Kennedy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Paeonol Attenuates Methotrexate-Induced Cardiac Toxicity in Rats by Inhibiting Oxidative Stress and Suppressing TLR4-Induced NF-κB Inflammatory Pathway
Abdulla Y. Al-Taher et al.
MEDIATORS OF INFLAMMATION (2020)
Oxidative Stress in Radiation-Induced Cardiotoxicity
Zhang Ping et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Calycosin ameliorates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and inflammation via the sirtuin 1-NOD-like receptor protein 3 pathway
Jinghui Zhai et al.
PHYTOTHERAPY RESEARCH (2020)
Metabolism, Epigenetics, and Causal Inference in Heart Failure
Todd H. Kimball et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
EGFR Inhibitor Gefitinib Induces Cardiotoxicity through the Modulation of Cardiac PTEN/Akt/FoxO3a Pathway and Reactive Metabolites Formation: In Vivo and in Vitro Rat Studies
Ali Alhoshani et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
Kendall B. Wallace et al.
CIRCULATION RESEARCH (2020)
The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a
Dong Han et al.
CIRCULATION RESEARCH (2020)
Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease
Joseph Pierre Aboumsallem et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
Yingying Wang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Liraglutide attenuates gefitinib-induced cardiotoxicity and promotes cardioprotection through the regulation of MAPK/NF-κB signaling pathways
Abdullah F. AlAsmari et al.
SAUDI PHARMACEUTICAL JOURNAL (2020)
Fatal heart disease among cancer patients
Kelsey C. Stoltzfus et al.
NATURE COMMUNICATIONS (2020)
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
Joerg Herrmann
NATURE REVIEWS CARDIOLOGY (2020)
Curcumin attenuates bevacizumab-induced toxicity via suppressing oxidative stress and preventing mitochondrial dysfunction in heart mitochondria
Nima Shokouhi Sabet et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
Sergio Rius-Perez et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Early Cardiac Remodeling Promotes Tumor Growth and Metastasis
Shimrit Avraham et al.
CIRCULATION (2020)
Analysis of a breast cancer mathematical model by a new method to find an optimal protocol for HER2-positive cancer
OPhir Nave et al.
BIOSYSTEMS (2020)
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Berberine: A novel therapeutic strategy for cancer
Parisa Samadi et al.
IUBMB LIFE (2020)
Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity
Tomonori Tadokoro et al.
JCI INSIGHT (2020)
Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
Himani Kumari et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Chemistry of Fluorinated Pyrimidines in the Era of Personalized Medicine
William H. Gmeiner
MOLECULES (2020)
Myocardial infarction accelerates breast cancer via innate immune reprogramming
Emma M. Corr et al.
NATURE MEDICINE (2020)
ATP-Sensitive Potassium Channels Mediate the Cardioprotective Effect of Panax notoginseng Saponins against Myocardial Ischaemia-Reperfusion Injury and Inflammatory Reaction
Ke Ning et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Cardiovascular complications after radiotherapy
Izabela Nabialek-Trojanowska et al.
CARDIOLOGY JOURNAL (2020)
Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
Alessandra Murabito et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Cardiovascular toxicities associated with immune checkpoint inhibitors
Jiun-Ruey Hu et al.
CARDIOVASCULAR RESEARCH (2019)
Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision
Ashif Iqubal et al.
LIFE SCIENCES (2019)
Ferroptosis as a target for protection against cardiomyopathy
Xuexian Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
Chowdhury S. Abdullah et al.
SCIENTIFIC REPORTS (2019)
Cardioprotective Potential of Plant-Derived Molecules: A Scientific and Medicinal Approach
Syed Muhammad Ali Shah et al.
DOSE-RESPONSE (2019)
Cisplatin: The first metal based anticancer drug
Sumit Ghosh
BIOORGANIC CHEMISTRY (2019)
HER2+breast cancer treatment and cardiotoxicity: monitoring and management
Guy Jerusalem et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Network Pharmacology-Based Prediction and Verification of the Targets and Mechanism for Panax Notoginseng Saponins against Coronary Heart Disease
Yan Dong et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Tumor Microenvironment as A Game Changer in Cancer Radiotherapy
Magdalena Jarosz-Biej et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Advances in capillary electrophoresis for the life sciences
Javier Sastre Torano et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)
Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring
Nadine Wenningmann et al.
MOLECULAR PHARMACOLOGY (2019)
Modern radiotherapy for head and neck cancer
Daniela Alterio et al.
SEMINARS IN ONCOLOGY (2019)
Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies
Aristeidis Seretis et al.
SCIENTIFIC REPORTS (2019)
Sirt3 promotes sensitivity to sunitinib-induced cardiotoxicity via inhibition of GTSP1/JNK/autophagy pathway in vivo and in vitro
Yi Yang et al.
ARCHIVES OF TOXICOLOGY (2019)
Advances in Toxicological Research of the Anticancer Drug Cisplatin
Luyu Qi et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2019)
Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress
Jiamao Lin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function
Panxia Wang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes
Alina Hanf et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Mitochondrial oxidative stress plays a critical role in the cardiotoxicity of sunitinib Running title: Sunitinib and oxidative stress in hearts
Jamal Bouitbir et al.
TOXICOLOGY (2019)
CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC
Francesco Morra et al.
CANCERS (2019)
Safety and Efficacy Profile of Neratinib: A Systematic Review and Meta-Analysis of 23 Prospective Clinical Trials
Zhihang Tao et al.
CLINICAL DRUG INVESTIGATION (2019)
Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma
Caiyan Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Adjuvant external beam radiotherapy for locally invasive papillary thyroid cancer
Uchechukwu C. Megwalu et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease
Matthias Totzeck et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
miR-212/132 Cluster Modulation Prevents Doxorubicin-Mediated Atrophy and Cardiotoxicity
Shashi Kumar Gupta et al.
MOLECULAR THERAPY (2019)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway
Yan-Zhao Wu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK/mTOR/autophagy pathway
Yi Yang et al.
PHARMACEUTICAL BIOLOGY (2019)
Radiation-induced heart disease: a review of classification, mechanism and prevention
Heru Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Osimertinib-Induced Cardiotoxicity A Retrospective Review of the FDA Adverse Events Reporting System (FAERS)
Kartik Anand et al.
JACC: CARDIOONCOLOGY (2019)
Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report
Xia Yang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Cardiotoxicity evaluation of nine alkaloids from Rhizoma Coptis
M. Y. Zhang et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2018)
Neferine modulates IGF-1R/Nrf2 signaling in doxorubicin treated H9c2 cardiomyoblasts
Lohanathan Bharathi Priya et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Heart Failure Stimulates Tumor Growth by Circulating Factors
Wouter C. Meijers et al.
CIRCULATION (2018)
Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth
Mingchuan Li et al.
CIRCULATION (2018)
Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives
Rajesh K. Singh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
Monica Samuel Avila et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer
Aniello Cerrato et al.
MOLECULAR CANCER (2018)
Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin
Souleymane Abdoul-Azize et al.
ONCOGENE (2018)
Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway
Jian Yin et al.
TOXICOLOGY IN VITRO (2018)
Tongmai Yangxin pills anti-oxidative stress alleviates cisplatin-induced cardiotoxicity: Network pharmacology analysis and experimental evidence
Yameng Cui et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
The current status of intraoperative radiation therapy in breast cancer: Challenges and promises
Julie A. Bradley
BREAST JOURNAL (2018)
Ganoderma atrum polysaccharide improves doxorubicin-induced cardiotoxicity in mice by regulation of apoptotic pathway in mitochondria
Wen-Juan Li et al.
CARBOHYDRATE POLYMERS (2018)
Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ
Huan He et al.
FOOD & FUNCTION (2018)
Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs
Yishui Lian et al.
CLINICAL EPIGENETICS (2018)
Trastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction
Somaira Nowsheen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
The safety of bevazicumab for the treatment of ovarian cancer
Carolina Bottoni et al.
EXPERT OPINION ON DRUG SAFETY (2018)
HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving alpha-tubulin acetylation
Rui Song et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Joe-Elie Salem et al.
LANCET ONCOLOGY (2018)
Heart failure in cancer: role of checkpoint inhibitors
Murilo Delgobo et al.
JOURNAL OF THORACIC DISEASE (2018)
Coenzyme Q10 in the treatment of heart failure: A systematic review of systematic reviews
Mehdi Jafari et al.
INDIAN HEART JOURNAL (2018)
Increased Afterload Augments Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model
Rachel Truitt et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
Cardiotoxicity with vascular endothelial growth factor inhibitor therapy
Rhian M. Touyz et al.
NPJ PRECISION ONCOLOGY (2018)
Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system
Kun Zou et al.
ACTA PHARMACOLOGICA SINICA (2017)
Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy
Ghasem Janbabai et al.
CARDIOVASCULAR TOXICOLOGY (2017)
Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts
Pei-Yu Chen et al.
ENVIRONMENTAL TOXICOLOGY (2017)
Cardiovascular disease in cancer survivors
Tochi M. Okwuosa et al.
POSTGRADUATE MEDICAL JOURNAL (2017)
Autophagic dysregulation in doxorubicin cardiomyopathy
Jordan J. Bartlett et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Traditional Chinese Medicine for Cardiovascular Disease Evidence and Potential Mechanisms
Panpan Hao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Cardiac Dysfunction Caused by Osimertinib
Takuya Oyakawa et al.
Journal of Thoracic Oncology (2017)
ING5 suppresses breast cancer progression and is regulated by miR-24
Shufang Cui et al.
MOLECULAR CANCER (2017)
Evaluation of the Cardiotoxicity of Evodiamine In Vitro and In Vivo
Weifeng Yang et al.
MOLECULES (2017)
Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity
Andre Ferreira et al.
TOXICOLOGY (2017)
Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity
Lan Cui et al.
TOXICOLOGY LETTERS (2017)
Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial
Wei Hao et al.
TRIALS (2017)
Luteolin: A Flavonoid that Has Multiple Cardio-Protective Effects and Its Molecular Mechanisms
Yuanyuan Luo et al.
FRONTIERS IN PHARMACOLOGY (2017)
Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways
Eman M. Mantawy et al.
SCIENTIFIC REPORTS (2017)
Effects of Ganoderma lucidum polysaccharides against doxorubicin-induced cardiotoxicity
Fan Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Precision cardio-oncology: understanding the cardiotoxicity of cancer therapy
Xinqiang Han et al.
NPJ PRECISION ONCOLOGY (2017)
Cardiac toxicities of lapatinib in patients with breast cancer and other HER2-positive cancers: a meta-analysis
Hye Duck Choi et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Role of Platelet-Derived Transforming Growth Factor-β1 and Reactive Oxygen Species in Radiation-Induced Organ Fibrosis
Jasimuddin Ahamed et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment
Diwakar Jain et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Tyrosine kinase-targeting drugs-associated heart failure
N. Gronich et al.
BRITISH JOURNAL OF CANCER (2017)
Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview
Pierantonio Menna et al.
CHEMOTHERAPY (2017)
Adjuvant chemotherapy with bevacizumab (i.p.) can prolong survival time of patients with advanced ovarian cancer after cytoreduction
F. Du et al.
NEOPLASMA (2017)
Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy
Jordan J. Bartlett et al.
BIOCHEMICAL JOURNAL (2016)
The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34
Jonathan M. Backer
BIOCHEMICAL JOURNAL (2016)
Antitumor polysaccharides from mushrooms: a review on the structural characteristics, antitumor mechanisms and immunomodulating activities
Xin Meng et al.
CARBOHYDRATE RESEARCH (2016)
Spironolactone Attenuates Doxorubicin-induced Cardiotoxicity in Rats
Guangzhong Liu et al.
CARDIOVASCULAR THERAPEUTICS (2016)
Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification
Dan L. Li et al.
CIRCULATION (2016)
Cardio-Oncology An Update on Cardiotoxicity of Cancer-Related Treatment
Carrie G. Lenneman et al.
CIRCULATION RESEARCH (2016)
Aging and Autophagy in the Heart
Akihiro Shirakabe et al.
CIRCULATION RESEARCH (2016)
The cardioprotective effects of L-carnitine on rat cardiac injury, apoptosis, and oxidative stress caused by amethopterin
Ehab Tousson et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2016)
Safety of gefitinib in non-small cell lung cancer treatment
Emily Han-Chung Hsiue et al.
EXPERT OPINION ON DRUG SAFETY (2016)
The protective effect of herbal polysaccharides on ischemia-reperfusion injury
Qianqian Dong et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy
Clelia Madeddu et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2016)
Inflammatory and fibrotic processes are involved in the cardiotoxic effect of sunitinib: Protective role of L-carnitine
Antonio J. Blanca et al.
TOXICOLOGY LETTERS (2016)
Oncocardiology-Past, Present, and Future A Review
Edward T. H. Yeh et al.
JAMA CARDIOLOGY (2016)
Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation
David Conen et al.
JAMA CARDIOLOGY (2016)
Anthracyclines potentiate anti-tumor immunity: A new opportunity for chemoimmunotherapy
Zhigang Zhang et al.
CANCER LETTERS (2015)
A case of chemotherapy-induced congestive heart failure successfully treated with Chinese herbal medicine
Bei-Yu Wu et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2015)
Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity (vol 74, pg 252, 2014)
Debapriya Dutta et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Total saponins from Aralia taibaiensis protect against myocardial ischemia/reperfusion injury through AMPK pathway
Jiajia Yan et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity
Jun Gu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Cancer immunotherapy: harnessing the immune system to battle cancer
Yiping Yang
JOURNAL OF CLINICAL INVESTIGATION (2015)
Cardiotoxicity of anticancer treatments
Michael S. Ewer et al.
NATURE REVIEWS CARDIOLOGY (2015)
Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment
Qian Guo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction
Hasahya Tony et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Ginsenoside Rg3 antagonizes adriamycin-induced cardiotoxicity by improving endothelial dysfunction from oxidative stress via upregulating the Nrf2-ARE pathway through the activation of akt
Xiaoying Wang et al.
PHYTOMEDICINE (2015)
Cancer and Cardiovascular Disease: The Complex Labyrinth
Susan Dent et al.
JOURNAL OF ONCOLOGY (2015)
Radiation-induced heart disease: pathologic abnormalites and putative mechanisms
Neil K. Taunk et al.
FRONTIERS IN ONCOLOGY (2015)
Protective effects of spironolactone against anthracycline-induced cardiomyopathy
Mahmut Akpek et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes
Chiara Focaccetti et al.
PLOS ONE (2015)
Downregulation of Stanniocalcin 1 Is Responsible for Sorafenib-Induced Cardiotoxicity
Miko Kawabata et al.
TOXICOLOGICAL SCIENCES (2015)
Therapeutic Potential of Dietary Phenolic Acids
Venkata Saibabu et al.
ADVANCES IN PHARMACOLOGICAL SCIENCES (2015)
Ophiopogonin D Attenuates Doxorubicin-Induced Autophagic Cell Death by Relieving Mitochondrial Damage In Vitro and In Vivo
Ying-Yu Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK
Xue Wang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis
Lei Wang et al.
CARCINOGENESIS (2014)
Topoisomerase 2 beta: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity
P. Vejpongsa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Ellagic Acid Induces Apoptosis in TSGH8301 Human Bladder Cancer Cells Through the Endoplasmic Reticulum Stress- and Mitochondria-Dependent Signaling Pathways
Chin-Chih Ho et al.
ENVIRONMENTAL TOXICOLOGY (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Risk of cardiovascular toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis
Omar Abdel-Rahman et al.
FUTURE ONCOLOGY (2014)
NOVEL DEVELOPMENTS IN THE USE OF ANTIMETABOLITES
Godefridus J. Peters
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2014)
Astragalus Polysaccharide Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the PI3k/Akt and p38MAPK Pathways
Yuan Cao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction
Siying Li et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
Anne Polk et al.
BMC PHARMACOLOGY & TOXICOLOGY (2014)
Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases
Masaru Katoh
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2014)
Adverse Effects of Doxorubicin and Its Metabolic Product on Cardiac RyR2 and SERCA2A
Amy D. Hanna et al.
MOLECULAR PHARMACOLOGY (2014)
Acute changes in endothelial function with cisplatin among germ cell tumor (GCT) patients (Pts).
Darren Richard Feldman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Cardioprotective potential of N,α-L-rhamnopyranosyl vincosamide, an indole alkaloid, isolated from the leaves of Moringa oleifera in isoproterenol induced cardiotoxic rats: In vivo and in vitro studies
Sunanda Panda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Polyphenols, Inflammation, and Cardiovascular Disease
Christy C. Tangney et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Cardioprotective effect of Saraca indica against cyclophosphamide induced cardiotoxicity in rats: A biochemical, electrocardiographic and histopathological study
A. H. M. Viswanatha Swamy et al.
INDIAN JOURNAL OF PHARMACOLOGY (2013)
Patients With Heart Failure Have an Increased Risk of Incident Cancer
Tal Hasin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Protective effect of Hypericum hircinum on doxorubicin-induced cardiotoxicity in rats
Sudeep Shah et al.
NATURAL PRODUCT RESEARCH (2013)
ULK1 targets Beclin-1 in autophagy
Volodymyr Y. Nazarko et al.
NATURE CELL BIOLOGY (2013)
Targeted cancer therapy - Are the days of systemic chemotherapy numbered?
Won Duk Joo et al.
MATURITAS (2013)
Does spironolactone ameliorate trastuzumab-induced cardiac toxicity?
Guler Yavas et al.
MEDICAL HYPOTHESES (2013)
Antiangiogenic Effects of P-Coumaric Acid in Human Endothelial Cells
Chang-Seok Kong et al.
PHYTOTHERAPY RESEARCH (2013)
Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice
M. Khair ElZarrad et al.
PLOS ONE (2013)
Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart
Atsushi Hoshino et al.
NATURE COMMUNICATIONS (2013)
Anti-cancer potential of flavonoids: recent trends and future perspectives
Priya Batra et al.
3 BIOTECH (2013)
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
G. Curigliano et al.
ANNALS OF ONCOLOGY (2012)
Venous thromboembolism and cancer
Donald G. MacLellan et al.
ANZ JOURNAL OF SURGERY (2012)
Anticancer polysaccharides from natural resources: A review of recent research
Aizhen Zong et al.
CARBOHYDRATE POLYMERS (2012)
Breast Cancer Treatment and Adverse Cardiac Events: What Are the Molecular Mechanisms?
Laura Roca-Alonso et al.
CARDIOLOGY (2012)
Future perspectives of personalized medicine in traditional Chinese medicine: A systems biology approach
Aihua Zhang et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2012)
Flavonoid-rich apples and nitrate-rich spinach augment nitric oxide status and improve endothelial function in healthy men and women: a randomized controlled trial
Catherine P. Bondonno et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint
Tohru Yamamori et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Rac1 Protein Signaling Is Required for DNA Damage Response Stimulated by Topoisomerase II Poisons
Stefanie C. Huelsenbeck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity
Jonathan L. Marks et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2012)
Chronic Anthracycline Cardiotoxicity: Molecular and Functional Analysis with Focus on Nuclear Factor Erythroid 2-Related Factor 2 and Mitochondrial Biogenesis Pathways
Eduard Jirkovsky et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Botanical Flavonoids on Coronary Heart Disease
Chong-Zhi Wang et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2011)
The relative contribution of pro-apoptotic p53-target genes in the triggering of apoptosis following DNA damage in vitro and in vivo
Kageaki Kuribayashi et al.
CELL CYCLE (2011)
A Novel Preclinical Strategy for Identifying Cardiotoxic Kinase Inhibitors and Mechanisms of Cardiotoxicity
Hui Cheng et al.
CIRCULATION RESEARCH (2011)
Cisplatin-induced cardiotoxicity Mechanisms and cardioprotective strategies
El-Sayed E. El-Awady et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer
Govind Ragupathi et al.
EXPERT REVIEW OF VACCINES (2011)
Incidence and Risk of Congestive Heart Failure in Patients With Renal and Nonrenal Cell Carcinoma Treated With Sunitinib
Christopher J. Richards et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Berberine Attenuates Doxorubicin-induced Cardiotoxicity in Mice
X. Zhao et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes
Can M. Sag et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Recurrent myocardial infarction associated with gefitinib therapy
Donald R. Lynch et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)
New Insights into Molecular Mechanisms of Sunitinib-Associated Side Effects
Guadalupe Aparicio-Gallego et al.
MOLECULAR CANCER THERAPEUTICS (2011)
In vitro and in vivo study on the antioxidant activity of dexrazoxane
Fabio Galetta et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (vol 119, pg e391, 2009)
Hunt
CIRCULATION (2010)
Cisplatin compromises myocardial contractile function and mitochondrial ultrastructure: Role of endoplasmic reticulum stress
Heng Ma et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)
PD-1 deficiency results in the development of fatal myocarditis in MRL mice
Jian Wang et al.
INTERNATIONAL IMMUNOLOGY (2010)
Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death
Satoru Kobayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Autophagy plays an important role in Sunitinib-mediated cell death in H9c2 cardiac muscle cells
Yuqin Zhao et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart
David Montaigne et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Effects of methotrexate on the developments of heart and vessel in zebrafish
Shuna Sun et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2009)
Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer
William B. Parker
CHEMICAL REVIEWS (2009)
Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways
Leo I. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Fulminant fatal cardiotoxicity following cyclophosphamide therapy
Minako Katayama et al.
JOURNAL OF CARDIOLOGY (2009)
PGC-1α and ERRα target gene downregulation is a signature of the failing human heart
Smita Sihag et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Cardiovascular Complications of Cancer Therapy Incidence, Pathogenesis, Diagnosis, and Management
Edward T. H. Yeh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
Paul M. Ridker
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Decreased Oxygen Transfer Capacity of Erythrocytes as a Cause of 5-Fluorouracil Related Ischemia
Ivan Spasojevic et al.
MOLECULES (2009)
Cyclophosphamide and cancer: golden anniversary
Ashkan Emadi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Effects of Methotrexate on Plasma Cytokines and Cardiac Remodeling and Function in Postmyocarditis Rats
Zhengang Zhang et al.
MEDIATORS OF INFLAMMATION (2009)
Salvianolic acids prevent acute doxorubicin cardiotoxicity in mice through suppression of oxidative stress
Baohong Jiang et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol
Marjan Boerma et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice
Julie A. Lucas et al.
JOURNAL OF IMMUNOLOGY (2008)
The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity
Lonnie P. Swift et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Tammy F. Chu et al.
LANCET (2007)
Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure
Jianzhu Luo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Protective effect of Lycium barbarum on doxorubicin-induced cardiotoxicity
Yan-Fei Xin et al.
PHYTOTHERAPY RESEARCH (2007)
Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies
Mariangela Sebastiani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Topoisomerase IIβ-Mediated DNA double-strand breaks:: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane
Yi Lisa Lyu et al.
CANCER RESEARCH (2007)
Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials
Gustavo A. Viani et al.
BMC CANCER (2007)
Protective effects of carvedilol against anthracycline-induced cardiomyopathy
Nihat Kalay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure
Eva van Rooij et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy
M Marty et al.
ANNALS OF ONCOLOGY (2006)
DNA damage-induced cell death by apoptosis
Wynand P. Roos et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies
KA Wouters et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Pathology of radiation and anthracycline cardiotoxicity
GJ Berry et al.
PEDIATRIC BLOOD & CANCER (2005)
Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction
JM Berthiaume et al.
CARDIOVASCULAR TOXICOLOGY (2005)
Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its antineoplastic activity
GC Jagetia et al.
PHYTOTHERAPY RESEARCH (2005)
Micro albuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer
J Nuver et al.
EUROPEAN JOURNAL OF CANCER (2004)
Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats
M Naziroglu et al.
TOXICOLOGY (2004)
Interaction model for anthracycline activity against DNA topoisomerase II
S Moro et al.
BIOCHEMISTRY (2004)
Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity
PJ Oliveira et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro
P Spallarossa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)
Anthracycline cardiotoxicity in transgenic mice overexpressing SR Ca2+-ATPase
BE Burke et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion
JA Crestanello et al.
JOURNAL OF SURGICAL RESEARCH (2002)
Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats
MAA El-Aziz et al.
JOURNAL OF APPLIED TOXICOLOGY (2001)
Evidence for health benefits of plant phenols: local or systemic effects?
PCH Hollman
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2001)
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines
H Ozer et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
